World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Merck Plans Radical Overhaul of Drug R&D Unit
Keywords:
Merck's decision to organize R&D using four innovation hubs in Boston, San Francisco, London and Shanghai. Merck currently lacks a large R&D presence in London and it has commercial operations in Shanghai. Experts say innovation centers enable drug companies to take advantage of academic research at an early stage. Pfizer and other companies are also pursuing a similiar strategy. The new head of R&D at Merck, Dr, Perlmutter plans to shrink staff and focus on promising areas such as immunoterapies for treating cancer and vaccines. Perlmutter comes from Amgen and is bringing people who he worked with at Amgen. The focus is also shifting to tapping the new science behind dieseases.
Merck R&D organized using innovation hubs in Boston, San Francisco, London and Shanghai in 2014-2015
12/28/2013
Grouped Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Buses for Tech Workers in San Francisco Will Pay Fee
New York Times 01/21/2014
Merck research and development
12/11/2007
Grouped Articles
Merck R&D Job Cuts Strip Layer of Senior Management
Wall Street Journal 06/15/2013
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Merck to Continue Development Of Cholesterol, Obesity Drugs
Wall Street Journal 12/11/2007
BusinessWeek 05/08/2008
Merck to Develop Biotech Generics
Wall Street Journal 12/10/2008
Wall Street Journal 11/18/2010
Merck strategies
07/30/2011
Grouped Articles
Merck R&D Job Cuts Strip Layer of Senior Management
Wall Street Journal 06/15/2013
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Merck Sells Consumer Care Business to Bayer
New York Times 05/06/2014
Merck in $8.4 Billion Deal for Cubist, Big Maker of Antibiotics
New York Times 12/08/2014
Merck’s Self-Medication Is Welcome
Wall Street Journal 03/26/2015
Merck to Cut 13,000 More Jobs as Patents Expire
Wall Street Journal 07/30/2011
Merck performance
07/30/2011
Grouped Articles
Merck R&D Job Cuts Strip Layer of Senior Management
Wall Street Journal 06/15/2013
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Merck Sells Consumer Care Business to Bayer
New York Times 05/06/2014
Merck’s Self-Medication Is Welcome
Wall Street Journal 03/26/2015
Merck to Cut 13,000 More Jobs as Patents Expire
Wall Street Journal 07/30/2011
Merck Chairman Clark To Retire; CEO Frazier to Take Over
Wall Street Journal 10/06/2011
Merck restructuring
12/10/2008
Grouped Articles
Merck R&D Job Cuts Strip Layer of Senior Management
Wall Street Journal 06/15/2013
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Merck Restructuring Puts a Focus on Generic Drugs
New York Times 12/10/2008
Merckles Plan to Shed Drug Firm
Wall Street Journal 01/08/2009
Merck Plans to Lay Off 15% of Its Work Force
New York Times 07/08/2010
Wall Street Journal 07/09/2010
Pfizer and Merck organize R&D using international innovation hubs- 2011-2015
05/02/2011
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer Chief
Wall Street Journal 05/02/2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us